QUIDELORTHO CORP Non Peo Neo Avg Total Comp Amt
QUIDELORTHO CORP (QDEL) reported Non Peo Neo Avg Total Comp Amt of $3.17 million for the 12-month period ending 2025-12-28, per its DEF 14A filed 2026-04-27.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-27
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-28 | $3.17M DEF 14A · filed 2026-04-27 |
| 2024-12-29 | $3.56M DEF 14A · filed 2026-04-27 |
| 2023-12-31 | $2.92M DEF 14A · filed 2026-04-27 |
| 2023-01-01 | $3.83M DEF 14A · filed 2026-04-27 |
| 2022-01-02 | $2.47M DEF 14A · filed 2026-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |